ArticleScientific reports2025
Evaluation of seven Theobroma cacao clones grown in Terai region of India for nutritional composition and bioactive compounds.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Analysis of biochemical composition along with the yield and morphological characteristics of cocoa clones provide a stronger base for identification of clones for commercial cultivation. Seven cocoa clones released from ICAR-CPCRI Research Station, Vittal, India, were evaluated for their morphological and biochemical quality parameters after processing, when cultivated in Terai region of West Bengal, India, being one of the non-traditional areas for cocoa cultivation having favourable soil and climatic conditions. The seven cocoa clones included in this study were VTLCH 2, VTLC 19 A, VTLC 61, VTLC 5, VTLC 8, VTLC 11 and VTLC 66. Experiments were conducted following Completely Randomized Design (CRD) with 3 replications. All quality parameters studied varied significantly (p ≤ 0.05) among the cocoa clones. Fermentation of all the cocoa clones was completed in 7 days, as observed by cut test and fermentation index. The clone VTLC 61 had higher pH, lowest free fatty acid and titratable acetic acid content, highest carbohydrate content, whereas highest fat content was observed in VTLC 66. But both the clones VTLC 61 and VTLC 66 showed certain amount of germinated and slaty beans after 7 days of fermentation. The clone VTLC 5 had low free fatty acid and titratable acetic acid content, highest protein content, good fat and carbohydrate content, highest anthocyanin and polyphenol content and antioxidant capacity. Considering all the quality parameters and the yield performance evaluated earlier, the clone VTLC 5 was identified as potential clone for commercial cultivation and processing in the Terai region of West Bengal in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.